AstraZeneca to buy MedImmune; Mergers and Acquisitions Continue!
This news is somewhat dated now but the M&A activity in the pharmaceutical industry continues. Now AsraZeneca is purchasing Medimmune for $15.6 billion.
AstraZeneca to buy MedImmune for $15.6B - Yahoo! News
The two main products of interest are the children’s respiratory drug Synagis and a refrigerated version of FluMist inhaled influenza vaccine. This follows the current trend of major pharma increasing interest in vaccines. Novartis purchased Chiron and both Sanofi-Aventis and GlaxoSmithKline have sizable vaccine businesses.
MedImmune had until recently, actively resisted any such take-over moves. I’m not sure why they finally relented and went forward with AstraZeneca. Maybe they finally got the price they wanted.
Technorati Tags: AstraZeneca, Medimmune, pharma M&A, pharmaceutical deals
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
